BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 23183435)

  • 1. In vitro interaction of voriconazole and anidulafungin against triazole-resistant Aspergillus fumigatus.
    Seyedmousavi S; Meletiadis J; Melchers WJ; Rijs AJ; Mouton JW; Verweij PE
    Antimicrob Agents Chemother; 2013 Feb; 57(2):796-803. PubMed ID: 23183435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro efficacy of the combination of voriconazole and anidulafungin against voriconazole-resistant cyp51A mutants of Aspergillus fumigatus.
    Krishnan-Natesan S; Wu W; Chandrasekar PH
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):135-7. PubMed ID: 22608136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.
    Mohammadi F; Hashemi SJ; Zoll J; Melchers WJ; Rafati H; Dehghan P; Rezaie S; Tolooe A; Tamadon Y; van der Lee HA; Verweij PE; Seyedmousavi S
    Antimicrob Agents Chemother; 2016 Jan; 60(1):387-92. PubMed ID: 26525787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics of anidulafungin against clinical Aspergillus fumigatus isolates in a nonneutropenic murine model of disseminated aspergillosis.
    Seyedmousavi S; Brüggemann RJ; Melchers WJ; Verweij PE; Mouton JW
    Antimicrob Agents Chemother; 2013 Jan; 57(1):303-8. PubMed ID: 23114773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insight into the Significance of Aspergillus fumigatus cyp51A Polymorphisms.
    Garcia-Rubio R; Alcazar-Fuoli L; Monteiro MC; Monzon S; Cuesta I; Pelaez T; Mellado E
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The strength of synergistic interaction between posaconazole and caspofungin depends on the underlying azole resistance mechanism of Aspergillus fumigatus.
    Mavridou E; Meletiadis J; Rijs A; Mouton JW; Verweij PE
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1738-44. PubMed ID: 25583716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.
    Buil JB; Rijs AJMM; Meis JF; Birch M; Law D; Melchers WJG; Verweij PE
    J Antimicrob Chemother; 2017 Sep; 72(9):2548-2552. PubMed ID: 28605488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis.
    Seyedmousavi S; Brüggemann RJ; Melchers WJ; Rijs AJ; Verweij PE; Mouton JW
    J Antimicrob Chemother; 2013 Feb; 68(2):385-93. PubMed ID: 23129729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological cutoff values for azoles and Aspergillus fumigatus based on a novel mathematical approach incorporating cyp51A sequence analysis.
    Meletiadis J; Mavridou E; Melchers WJ; Mouton JW; Verweij PE
    Antimicrob Agents Chemother; 2012 May; 56(5):2524-9. PubMed ID: 22330922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of a High-Resolution Melting Assay To Detect Azole Resistance in Aspergillus fumigatus.
    Bernal-Martínez L; Gil H; Rivero-Menéndez O; Gago S; Cuenca-Estrella M; Mellado E; Alastruey-Izquierdo A
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.
    Bader O; Weig M; Reichard U; Lugert R; Kuhns M; Christner M; Held J; Peter S; Schumacher U; Buchheidt D; Tintelnot K; Groß U;
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3513-7. PubMed ID: 23669382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamics and dose-response relationships of liposomal amphotericin B against different azole-resistant Aspergillus fumigatus isolates in a murine model of disseminated aspergillosis.
    Seyedmousavi S; Melchers WJ; Mouton JW; Verweij PE
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1866-71. PubMed ID: 23380732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms.
    Arendrup MC; Jensen RH; Cuenca-Estrella M
    Antimicrob Agents Chemother; 2016 Jan; 60(1):532-6. PubMed ID: 26552973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal expansion and emergence of environmental multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR₃₄/L98H mutations in the cyp51A gene in India.
    Chowdhary A; Kathuria S; Xu J; Sharma C; Sundar G; Singh PK; Gaur SN; Hagen F; Klaassen CH; Meis JF
    PLoS One; 2012; 7(12):e52871. PubMed ID: 23285210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro interaction of isavuconazole and anidulafungin against azole-susceptible and azole-resistant Aspergillus fumigatus isolates.
    Buil JB; Brüggemann RJM; Bedin Denardi L; Melchers WJG; Verweij PE
    J Antimicrob Chemother; 2020 Sep; 75(9):2582-2586. PubMed ID: 32516368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azole-resistant Aspergillus fumigatus Containing a 34-bp Tandem Repeat in cyp51A Promoter is Isolated from the Environment in Japan.
    Onishi K; Muhammad Sarumoh B; Hagiwara D; Watanabe A; Kamei K; Toyotome T
    Med Mycol J; 2017; 58(2):E67-E70. PubMed ID: 28566661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of voriconazole and anidulafungin for treatment of triazole-resistant aspergillus fumigatus in an in vitro model of invasive pulmonary aspergillosis.
    Jeans AR; Howard SJ; Al-Nakeeb Z; Goodwin J; Gregson L; Warn PA; Hope WW
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5180-5. PubMed ID: 22825124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands.
    van Ingen J; van der Lee HA; Rijs TA; Zoll J; Leenstra T; Melchers WJ; Verweij PE
    J Antimicrob Chemother; 2015 Jan; 70(1):178-81. PubMed ID: 25301884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro combination of anidulafungin and voriconazole against intrinsically azole-susceptible and -resistant Aspergillus spp.
    Planche V; Ducroz S; Alanio A; Bougnoux ME; Lortholary O; Dannaoui E
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4500-3. PubMed ID: 22615296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triazole Resistance in
    Zhang M; Feng CL; Chen F; He Q; Su X; Shi Y
    Chin Med J (Engl); 2017 Mar; 130(6):665-668. PubMed ID: 28303848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.